ST6GAL1 and cervical carcinoma: Knockdown of ST6GAL1 suppresses subcutaneous tumor growth and increases cisplatin sensitivity of cervical cancer cells (35); we therefore presumed that ST6GAL1 may be a candidate oncogenic mediator of HPV16 E6 protein.